FORUM annual lecture

The Academy’s FORUM annual lecture recognises a key individual working at the interface of academia, industry and healthcare and provides an opportunity to promote discussion amongst FORUM members, Academy Fellows and invited guests.

2019 - The promise of human genome editing for rare and genetic disease

Dr John Leonard, Chief Executive Officer, Intellia Therapeutics

Panel participants:

  • Dr Mathew Garnett, Group Leader, Wellcome Sanger Institute
  • Dr Nicola McCarthy, Business Unit Manager, Horizon Discovery
  • Dr Alison Kay, Patient representative
  • Dr Sarah Chan, Chancellor's Fellow, University of Edinburgh

2018 -Transforming healthcare through engineering and technology

Dr Omar Ishrak, Chair and Chief Executive Officer, Medtronic

Panel participants:

  • Professor Alison Noble OBE FRS FREng, Professor of Biomedical Engineering, University of Oxford
  • Professor Sebastien Ourselin, Head of the School of Biomedical Engineering & Imaging Sciences, King's College London
  • Professor Lionel Tarassenko CBE FREng FMedSci, Chair in Electrical Engineering, University of Oxford
  • Professor Chris Taylor OBE FREng, Professor of Medical Biophysics and Professor of Computer Science, University of Manchester

2017 - The mind-body interface
Professor Kevin Tracey, President and CEO, The Feinstein Institute for Medical Research

Panel participants:

  • Professor Ed Bullmore, Head of Department of Psychiatry, University of Cambridge
  • Professor Matthew Hotopf, Professor General Hospital Psychiatry, King's College London
  • Professor Brenda Penninx, Professor of Psychiatric Epidemiology, EMGO Institute for Health and Care Research, VU University Medical Center Amsterdam
  • Melissa Smith, Ophthalmology nurse and service user, East Sussex Healthcare NHS Trust

 2016 - What can research do to improve productivity in the NHS?
Dame Julie Moore, Chief Executive, University Hospitals Birmingham NHS Foundation Trust

Panel participants:

  • Dr Annette Doherty OBE, Senior Vice President of Product Development, GlaxoSmithKline
  • Dr Nicolaus Henke, Director of Healthcare Systems and Services Practice, McKinsey & Company
  • Rt Hon Stephen Dorrell, Chair, NHS Confederation and Senior Adviser, KPMG
  • Professor Sir Simon Wessely FMedSci, Chair of Psychological Medicine, King's College London and President, Royal College of Psychiatrists

2015 - A vision for the life sciences sector
Mr George Freeman MP, Parliamentary Under Secretary of State for Life Sciences

Panel participants:
  • Professor Sir John Bell GBE FRS HonFREng FMedSci, Regius Professor of Medicine, University of Oxford
  • Mr Chris Brinsmead CBE, Life Sciences Business Adviser
  • Mr John Jeans CBE, Chairman of Imanova, Chair of Cardiff University, Chair of UK Biocentre

2014 - Horizon scanning: looking ahead to 2025

  • Sir Gordon Duff, Chairman, Medicines and Healthcare Products Regulatory Agency
  • Professor Sir Malcolm Grant, Chair, NHS England
  • Professor Dame Nancy Rothwell, President and Vice- Chancellor, University of Manchester
  • Professor Patrick Vallance, President, Pharmaceuticals R&D, GSK

2013The changing pharmaceutical industry and the opportunity for precision medicine
Dr Ruth McKernan, Senior Vice President at Pfizer and Chief Scientific Officer at Neusentis

2012 - Frameworks of the Regulation of Medicinal Products: Opportunities and Challenges
Sir Alasdair Breckenridge CBE FRSE FMedSci, Chairman, MHRA

2011 - China's recent transformation into a major centre of medical research and innovation
Dr Jingwu Zang, Senior Vice President and Head of R&D China, GlaxoSmithKline

2010 - The importance of regulatory science to the healthcare portfolio
Dr Margaret Hamburg, Commissioner, Food and Drug Administration

2009 - UK life sciences - ensuring a healthy future
Lord Drayson of Kensington, Minister of State for Science & Innovation

2008 - The UK pharmaceutical industry - what does the future hold?
Andrew Witty, CEO Designate, GlaxoSmithKline

2007 - The highs and lows of academic-industrial collaborations
Professor Dame Nancy Rothwell FRS FMedSci

2006 - The human genome - realising the pharmaceutical opportunities
Dr Tim Rolph, Head of Discovery, Sandwich Laboratories, Pfizer Global R&D

2005 - Cancer research in the UK - areas of optimism & concern
Professor Alex Markham FMedSci, Chief Executive, Cancer Research UK

2004 - Can Europe compete in biomedical research?
Sir Tom McKillop, Chief Executive, AstraZeneca

2003 - Pharmacogenetics and personalised medicine
Dr Allen Roses, Senior Vice President, Genetics Research & Development, GlaxoSmithKline, North Carolina

Key contacts

Liberal Democrat Party Conference: Ask the experts: Coronavirus

Book Now

Conservative Party Conference: Ask the experts: Coronavirus

Book Now

Achieving Universal Health Coverage in Latin America Webinar

Book Now
View more
FB Twitter Instagram Youtube